FDA approves first Migraine patch


The Food and Drug Administration cleared the treatment, called Zecuity, which delivers sumatriptan, the most-prescribed migraine headache medication, through a mild electrical current, Conshohocken, Pennsylvania-based NuPathe said yesterday in a statement.

“We anticipate the product will be available for sale in the fourth quarter of this year,” Armando Anido, NuPathe’s chief executive officer, said in an interview. “We’re right now in conversations with a number of people for partnership in the United States.”


On the go? Not a problem. Now you can listen to STAR 94 on your iPhone and Android smartphone. Now how smart it that!